Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
---|
02/17/1998 | US5719123 Administering crystal form |
02/17/1998 | US5719122 Enhancing transdermal or transmucosal absorption by administering with a saturated polyglycolysed glyceride |
02/17/1998 | US5719121 Administering balhimycin to monogastric or polygastric animal as growth promoter |
02/17/1998 | US5719120 Use of endoglin polypeptides for modifying the regulatory activity of TGF-β |
02/17/1998 | US5719064 Autoimmune diseases |
02/17/1998 | US5719057 Genetic engineering |
02/17/1998 | US5719055 Insertion of dna into host gene; genetic engineering |
02/17/1998 | US5719044 Complexing |
02/17/1998 | US5719042 Nucleic acids encoding transcription factor APRF (acute phase response factor) |
02/17/1998 | US5719041 DNA encoding ecotin homologs |
02/17/1998 | US5719032 Melanoma and prostate cancer specific antibodies for immunodetection and immunotherapy |
02/17/1998 | US5718915 Antiviral liposome having coupled target-binding moiety and hydrolytic enzyme |
02/17/1998 | US5718900 Vaccines and methods for preventing and treating Fescue toxicosis in herbivores |
02/17/1998 | US5718899 High concentration of immunoglobulins |
02/17/1998 | US5718897 Contacting with purified clostridiopeptidase a collagenase and a growth factor to increase effects of collagenase |
02/17/1998 | US5718896 Contacting fluids with composition containing a haloperoxidase, a semen substrate-specific oxidase and a carrier |
02/17/1998 | US5718893 Use of G-CSF to reduce acute rejection |
02/17/1998 | US5718882 IKVAV peptide radiopharmaceutical applications |
02/17/1998 | CA1339679C Reduced size lhrh analogs |
02/17/1998 | CA1339678C Atrial natriuretic peptide derivative, its production and use thereof for treating gardiac or cerebral circulatory disease |
02/13/1998 | CA2212786A1 Novel glutamine:fructose-6-phosphate amidotransferase, its production and use |
02/12/1998 | WO1998005968A1 Brca1 associated protein (bap-1) and uses therefor |
02/12/1998 | WO1998005792A2 A novel human leptin receptor gene-related protein |
02/12/1998 | WO1998005787A1 A method for inhibiting immunoglobulin-induced toxicity resulting from the use of immunoglobulins in therapy and in vivo diagnosis |
02/12/1998 | WO1998005784A1 Dna molecule fragments encoding for cellular uptake of mycobacterium tuberculosis and uses thereof |
02/12/1998 | WO1998005783A1 A tumor necrosis factor related ligand |
02/12/1998 | WO1998005782A1 Testis-specific insulin homolog polypeptides |
02/12/1998 | WO1998005781A1 Secreted proteins and polynucleotides encoding them |
02/12/1998 | WO1998005780A2 Voltage-gated calcium channel antagonist and methods |
02/12/1998 | WO1998005779A1 Modified tie-2-receptor ligands |
02/12/1998 | WO1998005777A2 BCL-xη, A NOVEL BCL-x ISOFORM, AND USES RELATED THERETO |
02/12/1998 | WO1998005776A2 Secreted proteins and polynucleotides encoding them |
02/12/1998 | WO1998005775A1 Gene involved in cadasil, method of diagnosis and therapeutic application |
02/12/1998 | WO1998005774A1 Use of a human vascular endothelial cell growth factor gene for direct genetic therapy |
02/12/1998 | WO1998005772A1 Ectoparasite histamine releasing factor, genes and uses thereof |
02/12/1998 | WO1998005770A2 Antisense rna with a secondary structure |
02/12/1998 | WO1998005769A2 Antitumor antisense sequences directed against r1 and r2 components of ribonucleotide reductase |
02/12/1998 | WO1998005768A1 Improved nucleic acids encoding a chimeric glycosyltransferase |
02/12/1998 | WO1998005762A1 Plasminogen activator capable of being activated by thrombin |
02/12/1998 | WO1998005755A1 Detection, prevention and treatment of papillomatous digital dermatitis |
02/12/1998 | WO1998005687A1 Monoclonal antibody which agglutinates e. coli having the cs4-cfa/i family protein |
02/12/1998 | WO1998005685A2 Self-aligning peptides derived from elastin and other fibrous proteins |
02/12/1998 | WO1998005684A2 Mhc binding peptide oligomers and methods of use |
02/12/1998 | WO1998005683A1 Parathyroid hormone analogues for the treatment of osteoporosis |
02/12/1998 | WO1998005673A1 Methods for purifying nucleic acids |
02/12/1998 | WO1998005363A2 Polypeptides having a single covalently bound n-terminal water-soluble polymer |
02/12/1998 | WO1998005361A2 Long-acting drugs and pharmaceutical compositions comprising them |
02/12/1998 | WO1998005358A1 Sustained release preparations for injection containing gabexate mesylate |
02/12/1998 | WO1998005357A1 Anti-tnf antibodies and methotrexate in the treatment of autoimmune disease |
02/12/1998 | WO1998005354A2 Treatment of stress-induced skin disease by corticotropin releasing hormone antagonists and skin mast cell degranulation inhibitors |
02/12/1998 | WO1998005353A1 hCG AND DERIVATIVES AS MATRIX METALLOPROTEASES INHIBITORS |
02/12/1998 | WO1998005352A1 Hypothalamus-specific polypeptides |
02/12/1998 | WO1998005351A1 Methods for regulating gastrointestinal motility |
02/12/1998 | WO1998005350A1 Materials and methods for treatment of plaquing diseases |
02/12/1998 | WO1998005349A1 A novel method of detecting and treating cancer |
02/12/1998 | WO1998005348A1 Peptides responsive to antibodies against a consensus peptide of the cs4-cfa/i family proteins |
02/12/1998 | WO1998005347A1 Compounds that inhibit interaction between signal-transducing proteins and the glgf (pdz/dhr) domain and uses thereof |
02/12/1998 | WO1998005333A1 Use of beta-sheet mimetics as protease and kinase inhibitors and as inhibitors of transcription factors |
02/12/1998 | WO1998005331A2 Prevention or treatment of type 2 diabetes or cardiovascular disease with ppar modulators |
02/12/1998 | WO1998005309A1 Cyclosporin formulation |
02/12/1998 | WO1998005307A1 Transmural drug delivery method and apparatus |
02/12/1998 | WO1998005221A1 Drinkable, acid nutrient composition with long shelf life and health-promoting action |
02/12/1998 | WO1998000183A3 Methods and compositions for the treatment and repair of defects or lesions in cartilage or bone using functional barrier |
02/12/1998 | WO1997047271A3 Cellular vaccines and immunotherapeutics and methods for their preparation |
02/12/1998 | WO1997045139A3 Il-12 as an adjuvant for bordetella pertussis vaccines |
02/12/1998 | WO1997044354A3 Synthesis of soluble beta-sheet forming peptides |
02/12/1998 | WO1997043414A3 A basal cell carcinoma tumor suppressor gene |
02/12/1998 | WO1997019111A3 Monoclonal antibodies anti-cd6 and their uses |
02/12/1998 | DE19631919A1 Anti-Sinn-RNA mit Sekundärstruktur Anti-sense RNA secondary structure |
02/12/1998 | DE19629095A1 Verwendung von rekombinantem Myelinprotein zur Behandlung von T-Zell vermittelten Autoimmunerkrankungen des peripheren Nervensystems Use of recombinant myelin protein for the treatment of T-cell mediated autoimmune disorders of the peripheral nervous system |
02/12/1998 | CA2791778A1 Anti-tnf antibodies and methotrexate in the treatment of autoimmune disease |
02/12/1998 | CA2262994A1 Polypeptides having a single covalently bound n-terminal water-soluble polymer |
02/12/1998 | CA2262900A1 Use of beta-sheet mimetics as protease and kinase inhibitors and as inhibitors of transcription factors |
02/12/1998 | CA2262753A1 Voltage-gated calcium channel antagonist and methods |
02/12/1998 | CA2262751A1 Plasminogen activator capable of being activated by thrombin |
02/12/1998 | CA2262696A1 Bcl-xy, a novel bcl-x isoform, and uses related thereto |
02/12/1998 | CA2262624A1 A novel method of detecting and treating cancer |
02/12/1998 | CA2262479A1 Brca1 associated protein (bap-1) and uses therefor |
02/12/1998 | CA2262459A1 Gene involved in cadasil, method of diagnosis and therapeutic application |
02/12/1998 | CA2262446A1 Self-aligning peptides derived from elastin and other fibrous proteins |
02/12/1998 | CA2262415A1 Dna molecule fragments encoding for cellular uptake of mycobacterium tuberculosis and uses thereof |
02/12/1998 | CA2262405A1 A method for inhibiting immunoglobulin-induced toxicity resulting from the use of immunoglobulins in therapy and in vivo diagnosis |
02/12/1998 | CA2262401A1 Secreted proteins and polynucleotides encoding them |
02/12/1998 | CA2262399A1 Secreted proteins and polynucleotides encoding them |
02/12/1998 | CA2261573A1 A novel human leptin receptor gene-related protein |
02/12/1998 | CA2261565A1 Hypothalamus-specific polypeptides |
02/12/1998 | CA2260742A1 Compounds that inhibit interaction between signal-transducing proteins and the glgf (pdz/dhr) domain and uses thereof |
02/12/1998 | CA2233987A1 Materials and methods for treatment of plaquing diseases |
02/12/1998 | CA2233705A1 Improved nucleic acids encoding a chimeric glycosyltransferase |
02/12/1998 | CA2233570A1 Detection, prevention and treatment of papillomatous digital dermatitis |
02/11/1998 | EP0823478A2 Human cartilage gp 39-like gene |
02/11/1998 | EP0823476A2 Method for activating prothrombin to thrombin |
02/11/1998 | EP0823438A2 Human mucin cone protein: peptide fragments and antibodies thereto, and uses thereof in diagnostic and therapeutic methods |
02/11/1998 | EP0823257A1 Medicinal composition for curing thrombocytopenia |
02/11/1998 | EP0823256A1 Preventive and/or remedy for ischemic diseases |
02/11/1998 | EP0822991A1 Methods, polypeptides, nucleotide sequence of xor-6, a vitamin d-like receptor from xenopus |
02/11/1998 | EP0822988A2 Recombinant preduodenal lipases and polypeptide derivatives produced by plants, processes for obtaining them and their uses |
02/11/1998 | EP0822987A2 Polynucleotides and aminoacid sequences from staphylococcus aureus |
02/11/1998 | EP0822986A1 Antagonists of human interleukin-6 that are totally incapable of binding gp 130, and their use in the preparation of pharmaceutical compounds |
02/11/1998 | EP0822985A1 Variable fragments of immunoglobulins - use for therapeutic or veterinary purposes |